Geninus

Geninus ROE

The Return on Equity (ROE) of Geninus (389030.KQ) as of Oct 24, 2026 is -190.88 %. In the previous year, Return on Equity (ROE) was -55.19 % — a change of 245.84% (lower).

ROE

-190.88 %

YoY

245.84%

Last updated:

In 2025, Geninus's return on equity (ROE) was -190.88 %, a 245.84% increase from the -55.19 % ROE in the previous year.

The Geninus ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2018
-36.30 KRW
Jan 1, 2019
139.33 KRW
Jan 1, 2020
81.54 KRW
Jan 1, 2021
-17.38 KRW
Jan 1, 2022
-21.69 KRW
Jan 1, 2023
-28.08 KRW
Jan 1, 2024
-55.19 KRW
Jan 1, 2025
-190.88 KRW
The Geninus ROE history
YEARROEYoY
-190.88 %+245.84%
-55.19 %+96.54%
-28.08 %+29.47%
-21.69 %+24.82%
-17.38 %-121.31%
81.54 %-41.48%
139.33 %-483.84%
-36.30 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Geninus Stock analysis

What does Geninus do? Geninus Inc. generates revenue through the provision of single cell analysis services and genetic testing for disease prediction to the public. The company develops and manufactures genome analysis solutions, including cancer genome analysis based on tissue biopsy, and offers personal genetic testing services. Additionally, Geninus Inc. engages in software development and a rental business as part of its product portfolio. The primary customers are individuals seeking genetic insights for health management and healthcare providers requiring advanced genomic analysis tools. The company's products include NGS-based genome analysis technology, cancer genome analysis solutions, and personal genetic testing services. These offerings target healthcare institutions, medical professionals, and consumers interested in personalized health assessments. Geninus Inc. also develops software for genomic data processing, which supports its service delivery and rental business model. Revenue streams are derived from direct sales of genome analysis solutions, service fees for single cell and cancer genome analysis, and subscriptions for software and rental services. The firm's focus on NGS technology positions it within the biotechnology sector, serving both clinical and consumer markets with a range of genomic services and products. Geninus is one of the most popular companies on Eulerpool.

ROE Details

Decoding Geninus's Return on Equity (ROE)

Geninus's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Geninus's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Geninus's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Geninus’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Geninus stock

Return on Equity (ROE) of Geninus is -190.88 % in 2025.

Return on Equity (ROE) of Geninus changed from -55.19 % to -190.88 %, representing a 245.84% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Geninus since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Geninus with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Geninus

All Key Metrics — Geninus